| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director
2 companies
Brainard Diana is a Chief Executive Officer at Kalaris Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 1 sell.
Estimated insider holdings value: $5.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2022 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 29,135 | $4.33 | $126,256.52 | -5.6% | +89.8% | -4.6% | |
| Aug 3, 2020 | KLRS Kalaris Therapeutics, Inc. | Director | Buy | 6,300 | $17.00 | $107,100.00 | New | - | - |